Stockreport

Insmed files U.S. marketing application for inhaled amikacin for type of lung disease; shares up 2% [Seeking Alpha]

Insmed Incorporated  (INSM) 
Last insmed incorporated earnings: 4/30 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.insmed.com
PDF Insmed files U.S. marketing application for inhaled amikacin for type of lung disease; shares up 2%Insmed (INSM+1.6%)submits a New Drug Application (NDA) to the FDA seek [Read more]